| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 02/22/2012 | EP2419419A1 4-azetidinyl-1-phenyl-cyclohexane antagonists of ccr2 |
| 02/22/2012 | EP2419418A1 4-azetidinyl-1-heteroatom linked-cyclohexane antagonists of ccr2 |
| 02/22/2012 | EP2419417A1 4-azetidinyl-1-heteroaryl-cyclohexane antagonists of ccr2 |
| 02/22/2012 | EP2419411A1 Quinoxaline derivatives and their use for treating benign and malignant tumour disorders |
| 02/22/2012 | EP2419405A1 3-(phenoxypyrrolidin-3-yl-methyl)heteroaryl, 3-(phenylpyrrolidin-3-ylmethoxy)heteroaryl, and 3-(heteroarylpyrrolidin-3-ylmethoxy)heteroaryl compounds |
| 02/22/2012 | EP2419404A1 Anti-viral compounds |
| 02/22/2012 | EP2310382B1 Amidophenoxyindazoles useful as inhibitors of c-met |
| 02/22/2012 | EP2162440B1 Process for preparing 2-amino-5-cyanobenzoic acid derivatives |
| 02/22/2012 | EP1995240B1 Quinolone derivative or pharmaceutically acceptable salt thereof |
| 02/22/2012 | EP1963286B1 Pyrazinecarboxamide derivatives and plant disease controlling agents containing the same |
| 02/22/2012 | EP1937666B1 Substituted heterocyclic compounds with cxcr3 antagonist activity |
| 02/22/2012 | EP1778637B1 FKBP-binding composition and pharmaceutical use thereof |
| 02/22/2012 | EP1660440B1 Acyloxyalkyl carbamate prodrugs, methods of synthesis and use |
| 02/22/2012 | EP1534680B1 Prenylation inhibitors and methods of their synthesis and use |
| 02/22/2012 | CN1784388B 含氮杂环衍生物及使用该衍生物的有机电致发光元件 Nitrogen-containing heterocyclic derivative and the derivative is an organic electroluminescent element |
| 02/22/2012 | CN102361857A Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
| 02/22/2012 | CN102358738A 2,4-pyrimidinediamine compounds and uses of treating or preventing autoimmune diseases thereof |
| 02/22/2012 | CN102358736A Crystalline forms of 4-methyl-n-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide |
| 02/22/2012 | CN102358735A Low toxicity multiple independently target able drugs-nitrogen aromatic ring-containing CB1 receptor inhibitor with hydroxyl or substituted hydroxyl, and pharmaceutical use thereof |
| 02/22/2012 | CN102358731A 2-substituted-6,7-dimethoxy tetralin isoquinoline derivative, preparation method thereof, medicinal composition and application thereof |
| 02/22/2012 | CN102358729A 3-hydroxy- indol-2-one derivatives, anti-plant virus disease drugs adopting 3-hydroxy-indol-2-one derivatives as active ingredients, and application thereof |
| 02/22/2012 | CN101492416B 影响葡糖激酶的化合物 Effect of compound of glucokinase |
| 02/22/2012 | CN101203506B 杂环基氨基烷基取代的苯并咪唑 A heterocyclic group substituted with aminoalkyl benzimidazole |
| 02/21/2012 | US8119819 Malonyl-CoA decarboxylase inhibitors useful as metabolic modulators |
| 02/21/2012 | US8119811 Method for producing amide compound |
| 02/21/2012 | US8119810 Process for the preparation of a benzimidazole derivative |
| 02/21/2012 | US8119809 AMPK-activating heterocycloalkyloxy(hetero)aryl carboxamide, sulfonamide and amine compounds and methods for using the same |
| 02/21/2012 | US8119808 Tetrahydroquinoline derivatives as cannabinoid receptor modulators |
| 02/21/2012 | US8119805 Substituted disulfonamide compounds |
| 02/21/2012 | US8119797 Production method |
| 02/21/2012 | US8119796 Biphenyl compounds useful as muscarinic receptor antagonists |
| 02/21/2012 | US8119795 Triazole derivatives II |
| 02/21/2012 | US8119665 Aryl imidazoles and related compounds as C5a receptor modulators |
| 02/21/2012 | US8119664 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV) |
| 02/21/2012 | US8119663 Heteroaryl-substituted piperidines |
| 02/21/2012 | US8119650 Aminophenyl derivatives as novel inhibitors of histone deacetylase |
| 02/21/2012 | US8119631 Inhibitors of interleukin-1β converting enzyme |
| 02/21/2012 | US8119630 Benzodiazepine derivatives and pharmaceutical compositions containing them |
| 02/21/2012 | US8119627 Heterocyclic compounds as inhibitors of 17beta-HSD3 |
| 02/21/2012 | US8119624 Fused phenyl amido heterocyclic compounds |
| 02/21/2012 | US8119623 Pyrrolidin-2-ones |
| 02/21/2012 | CA2663984C Biaryl ether urea compounds |
| 02/21/2012 | CA2659184C Ep2 agonists |
| 02/21/2012 | CA2633077C Solid-state form of amg 706 and pharmaceutical compositions thereof |
| 02/21/2012 | CA2536787C Haloalkyl- and piperidine-substituted benzimidazole-derivatives |
| 02/21/2012 | CA2529207C 2,4-bis(trifluoroethoxy)pyridine compound and medicine containing the same |
| 02/21/2012 | CA2488372C Pyridazine derivatives which are phosphodiasterase iv inhibitors |
| 02/21/2012 | CA2478542C Aminoindazole derivatives, their method of preparation and intermediaries of this process as medicines and pharmaceutical compositions containing same |
| 02/21/2012 | CA2444031C 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 02/21/2012 | CA2400141C Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and preparation thereof |
| 02/16/2012 | WO2012021409A2 Anthraquinone Analogs |
| 02/16/2012 | WO2012020813A1 Fused-ring pyrrolidine derivative |
| 02/16/2012 | WO2012020787A1 Malignant lymphoma therapeutic agent |
| 02/16/2012 | WO2012020786A1 Pharmaceutical composition |
| 02/16/2012 | WO2012020780A1 Heterocyclic compound and use thereof |
| 02/16/2012 | WO2012020762A1 Hetero ring compound |
| 02/16/2012 | WO2012020749A1 Triazine derivative and pharmaceutical compound that contains same and exhibits analgesic activity |
| 02/16/2012 | WO2012020742A1 Novel heterocyclic derivatives and pharmaceutical composition containing same |
| 02/16/2012 | WO2012020738A1 Heterocyclic compound and use thereof |
| 02/16/2012 | WO2012020725A1 Heterocyclic derivative having npy y5 receptor antagonism |
| 02/16/2012 | WO2012020567A1 Acyl piperazine derivatives as ttx-s blockers |
| 02/16/2012 | WO2012020134A1 Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy |
| 02/16/2012 | WO2012020037A1 Heterocyclic antiviral compounds |
| 02/16/2012 | WO2012020036A1 Hepatitis c virus inhibitors |
| 02/16/2012 | WO2012020008A1 Inhibitors of bruton's tyrosine kinase |
| 02/16/2012 | US20120041208 Process for making quinolone compounds |
| 02/16/2012 | US20120041202 Preparation of C-Pyrazine-Methylamines |
| 02/16/2012 | US20120041030 Pyridine thio derivative, and pharmaceutical composition which contains same and has anti-helicobacter pylori action |
| 02/16/2012 | US20120041028 Benzimidazoles which have activity at m1 receptor and their uses in medicine |
| 02/16/2012 | US20120041027 Benzimidazoles which have activity at m1 receptor and their uses in medicine |
| 02/16/2012 | US20120041024 Quinolyl amines as kinase inhibitors |
| 02/16/2012 | US20120041019 Protease inhibitors |
| 02/16/2012 | US20120041001 Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 02/16/2012 | US20120040997 Vinyl-aryl derivatives for inflammation and immune-related uses |
| 02/16/2012 | US20120040993 Neuroprotective multifunctional compounds and pharmaceutical compositions comprising them |
| 02/16/2012 | US20120040991 3-azabicyclo [4.1.0] heptanes used as orexin antagonists |
| 02/16/2012 | US20120040990 Indol-3-y-carbonyl-piperidin and piperazin-derivatives |
| 02/16/2012 | US20120040983 Phthalazine Compounds as P38 Map Kinase Modulators and Methods of Use Thereof |
| 02/16/2012 | US20120040980 Quinazolinone compounds |
| 02/16/2012 | US20120040977 Inhibitors of hcv ns5a |
| 02/16/2012 | US20120040975 Bridged bicyclic heterocycle derivatives and methods of use thereof |
| 02/16/2012 | US20120040968 Diamino heterocyclic carboxamide compound |
| 02/16/2012 | US20120040967 Pyrazin-2-yl-pyridin-2-yl-amine and pyrazin-2-yl-pyrimidin-4-yl-amine Compounds and Their Use |
| 02/16/2012 | US20120040966 Anti-viral compounds, treatment, and assay |
| 02/16/2012 | US20120040964 N-substituted piperidines and their use as pharmaceuticals |
| 02/16/2012 | US20120040955 Fluoro substituted pyrimidine compounds as jak3 inhibitors |
| 02/16/2012 | US20120040953 Compounds for the Treatment of Metabolic Disorders |
| 02/16/2012 | US20120040952 Azetidines as histamine h3 receptor antagonists |
| 02/16/2012 | US20120040950 Isoindolinone inhibitors of phosphatidylinositol 3-kinase |
| 02/16/2012 | US20120040949 Inhibitors of Bruton's Tyrosine Kinase |
| 02/16/2012 | US20120040936 Cyclic compound having substituted phenyl group |
| 02/16/2012 | US20120040935 Compositions useful as inhibitors of voltage-gated ion channels |
| 02/16/2012 | US20120040933 9-(piperazinylalkyl) carbazoles as bax-modulators |
| 02/16/2012 | US20120040837 Insecticidal (1,3,5)-triazinyl phenyl hydrazones |
| 02/16/2012 | US20120040020 Compounds useful as inhibitors of atr kinase |
| 02/16/2012 | US20120039804 Novel Tricyclic Modulators of Cannabinoid Receptors |
| 02/16/2012 | US20120039803 Pretargeting kit, method and agents used therein |
| 02/16/2012 | US20120038996 Photoresist compositions |
| 02/16/2012 | US20120037900 Ambipolar host in organic light emitting diode |
| 02/16/2012 | CA2808435A1 Heterocyclic compound |